Research and Development

Showing 15 posts of 9600 posts found.

Lilly buys rights to novel diabetes drug

July 6, 2005 Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …

FDA approves first ‘ethnic’ heart drug

June 29, 2005 Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …

GSK sets up new R&D centre

June 1, 2005 Research and Development

GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …

Industry encouraged to invest more in pharmacy partnerships

May 27, 2005 Research and Development

Pharmaceutical companies should increase their investment in community pharmacists, according to a leading pharmacy spokesperson.Michael Holden, NHS development manager at …

Pfizer becomes competitive in oncology

May 24, 2005 Research and Development, Sales and Marketing

Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …

GSK makes strategic biotech acquisition

May 6, 2005 Research and Development, Sales and Marketing GSK, biotech

 GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …

Mixed news for AstraZeneca’s stroke drug Cerovive

May 4, 2005 Research and Development, Sales and Marketing

AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …

Labour makes clinical trials law a manifesto pledge

April 15, 2005 Research and Development

The Labour party has promised to introduce new legislation which would oblige pharmaceutical companies to publish clinical trial data for …

Novartis signs respiratory deal with UK biotech companies

April 14, 2005 Research and Development

Novartis has signed a deal with two UK biotech companies to develop and market a new treatment for chronic obstructive …

Serono hit by two late-stage failures

April 8, 2005 Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …
The Gateway to Local Adoption Series

Latest content